EP4027988A4 - Opioid independent surgical anesthetic - Google Patents
Opioid independent surgical anesthetic Download PDFInfo
- Publication number
- EP4027988A4 EP4027988A4 EP20862568.1A EP20862568A EP4027988A4 EP 4027988 A4 EP4027988 A4 EP 4027988A4 EP 20862568 A EP20862568 A EP 20862568A EP 4027988 A4 EP4027988 A4 EP 4027988A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- opioid
- independent surgical
- surgical anesthetic
- anesthetic
- independent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900369P | 2019-09-13 | 2019-09-13 | |
| US202063014788P | 2020-04-24 | 2020-04-24 | |
| PCT/US2020/050727 WO2021051080A1 (en) | 2019-09-13 | 2020-09-14 | Opioid independent surgical anesthetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4027988A1 EP4027988A1 (en) | 2022-07-20 |
| EP4027988A4 true EP4027988A4 (en) | 2023-09-13 |
Family
ID=74866515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20862568.1A Pending EP4027988A4 (en) | 2019-09-13 | 2020-09-14 | Opioid independent surgical anesthetic |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP4027988A4 (en) |
| WO (1) | WO2021051080A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5227165A (en) * | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
| CN103816111A (en) * | 2014-02-26 | 2014-05-28 | 中国人民解放军第二军医大学 | Ropivacaine nanometer lipid carrier temperature-sensitive in-situ gel and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6632457B1 (en) * | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
| DE10044545A1 (en) * | 2000-09-05 | 2002-04-04 | Roland Bodmeier | Retardpartikeldispersion |
| US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
| CN113197851A (en) * | 2015-05-06 | 2021-08-03 | 辛纳吉勒公司 | Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of use thereof |
-
2020
- 2020-09-14 EP EP20862568.1A patent/EP4027988A4/en active Pending
- 2020-09-14 WO PCT/US2020/050727 patent/WO2021051080A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5227165A (en) * | 1989-11-13 | 1993-07-13 | Nova Pharmaceutical Corporation | Liposphere delivery systems for local anesthetics |
| CN103816111A (en) * | 2014-02-26 | 2014-05-28 | 中国人民解放军第二军医大学 | Ropivacaine nanometer lipid carrier temperature-sensitive in-situ gel and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| JIA X ET AL: "Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 25, no. 19, 1 August 2004 (2004-08-01), pages 4797 - 4804, XP004505491, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2003.12.012 * |
| SANDRINE LEMOINE ET AL: "Effect of long-chain triglyceride lipid emulsion on bupivacaine-induced changes in electrophysiological parameters of rabbit Purkinje cells", FUNDAMENTAL & CLINICAL PHARMACOLOGY, ELSEVIER, PARIS, FR, vol. 28, no. 5, 27 November 2013 (2013-11-27), pages 481 - 488, XP071692366, ISSN: 0767-3981, DOI: 10.1111/FCP.12058 * |
| See also references of WO2021051080A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4027988A1 (en) | 2022-07-20 |
| WO2021051080A1 (en) | 2021-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283767B (en) | Intraoperative surgical event summary | |
| EP3908201C0 (en) | Instruments for medical stapling | |
| EP3777957B8 (en) | Connecting structure for medical use | |
| EP4003475A4 (en) | Patient interface | |
| EP3946535A4 (en) | Patient interface | |
| EP4054399A4 (en) | Surgical retractor | |
| EP3949884A4 (en) | Medical device | |
| EP3923721A4 (en) | Improved endoscope disinfectant | |
| EP3834749A4 (en) | Medical instrument | |
| EP3784153A4 (en) | Surgical clamp | |
| EP4037741A4 (en) | Inhaler | |
| EP4024114A4 (en) | Endoscope | |
| EP4024116A4 (en) | Endoscope | |
| EP3965876A4 (en) | Techniques for stimulation artefact elimination | |
| GB2588421B (en) | Surgical membrane | |
| EP4027988A4 (en) | Opioid independent surgical anesthetic | |
| EP3616667B8 (en) | Surgical table | |
| EP3827734A4 (en) | Sterilized adaptor | |
| HK40079655A (en) | Inhaler | |
| EP3919113A4 (en) | Medical instrument | |
| HK40064746A (en) | Tissue phantoms | |
| HK40065752A (en) | Ngf antagonists for medical use | |
| HK40082055A (en) | Therapeutic compounds | |
| AU2019904852A0 (en) | Patient Interface | |
| AU2019904513A0 (en) | Patient Interface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20220308 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230525 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61K0031138000 Ipc: A61P0023020000 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20230811 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/445 20060101ALI20230807BHEP Ipc: A61K 9/06 20060101ALI20230807BHEP Ipc: A61K 47/44 20170101ALI20230807BHEP Ipc: A61K 9/00 20060101ALI20230807BHEP Ipc: A61P 23/02 20060101AFI20230807BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20250627 |